by Andreas Kremer | Mar 11, 2024
A Cellular Immunotherapy Virtual Twin for Personalised Cancer Treatment Our journey with CERTAINTY is driven by a simple fact: while CAR T cell therapy has worked wonders for many, it is still unclear why some patients do not respond to therapy. Some patients see...
by Andreas Kremer | Jun 16, 2023
Luxembourg, June 14th 2023. Today a consortium of public and private entities announced the official launch of IDERHA (Integration of heterogenous Data and Evidence towards Regulatory & HTA Acceptance). The consortium aims to propel health care innovation in...
by Lisa Blum | Feb 3, 2021
Immune cells that are empowered by gene-engineering to seek and destroy cancer cells (engineered T cell therapy) constitute a transformative novel treatment that has the potential to cure cancer. Multiple new versions of this therapy are being developed for distinct...
by Lisa Blum | Oct 15, 2019
ITTM was certified in 2019 as one of the very first SMEs by the IMI EHDEN and since the is part of the EHDEN SME marketplace: https://www.ehden.eu/business-directory/ITTM offers services aroundOHDSI Software and Tools: Installation of the analytical infrastructure,...
